Indications for the use of apheresis technologies in managing lupus erythematosus have
undergone numerous conceptual changes since the procedure was automated in the 1960s …

PP is a safe, expensive, labor-intensive procedure. Its absolute SLE indications include
hyperviscosity, cryoglobulinemia, pulmonary hemorrhage and TTP. PP may be useful in …

The term apheresis derives from the Greek'to take by force'. Coined by Abel, Rowntree and
Turner in 1914 when these Johns Hopkins pharmacologists were studying artificial kidneys …

Standard treatment for severe systemic lupus erythematosus (SLE) consists of
corticosteroids and immunosuppressive drugs. A number of controlled studies purport to …

Systemic lupus erythematosus is a chronic autoimmune disease which commonly involves
the kidneys. Despite great improvement in survival over the past years due to …

The aim of this study is to investigate the clinical effects of cytapheresis using the Adacolumn
system (selective removal of circulating monocytes and granulocytes by means of an …

Apheresis has been effective as rescue therapy in patients with severe, therapy‐resistant,
systemic lupus erythematosus (SLE). Its benefit in patients with less severe but therapy …

SUMMARY AND CONCLUSIONS The growing number of anecdotal reports on the effect of
plasmapheresis in patients with active SLE suggests that plasmapheresis, particularly in …

Efficacy of plasma exchange in patients with systemic lupus erythematosus has not been
supported by the results of the first non-controlled and retrospective studies. Nonetheless …

Plasmapheresis was used as the sole treatment modality in 4 patients with systemic lupus
erythematosus. The presence of circulating immune complexes in this group of patients was …